Cartalax (60 caps)
Cartalax is a short-chain peptide that has tissue-specific activity on the cartilage tissue with direct DNA interaction. It is a first-class geroprotective and regenerative medicine.
The certificate of state registration number 184.108.40.206.U.9174.8.06
Cartalax® – peptide complex containing amino acids that contribute to the normalization of the function of cartilage and the musculoskeletal system.
A clinical study established the effectiveness of Cartalax® in the complex treatment of patients suffering from spinal osteochondrosis, osteoarthrosis, osteoporosis, after injuries and fractures, as well as in the prevention of sclerotic and degenerative processes in the spine and joints in the elderly people.